Published in Br J Rheumatol on December 01, 1994
New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet (2002) 2.39
Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet (1999) 1.68
Classical electrostatics in biology and chemistry. Science (1995) 17.26
Ankylosing spondylitis and HL-A 27. Lancet (1973) 11.99
Elective ventilation of potential organ donors. BMJ (1995) 5.50
Reiter's disease and HL-A 27. Lancet (1973) 4.10
Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int (1998) 4.03
The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol (1994) 3.82
Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV. J Med Genet (1992) 3.80
Reconciling the magnitude of the microscopic and macroscopic hydrophobic effects. Science (1991) 3.79
Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum (1997) 2.90
Oligoarthritis--a presenting feature of occult coeliac disease. Br J Rheumatol (1992) 2.84
Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) (1981) 2.84
Acute anterior uveitis and HL-A 27. Lancet (1973) 2.74
Extracting hydrophobic free energies from experimental data: relationship to protein folding and theoretical models. Biochemistry (1991) 2.46
Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation. J Biol Chem (1984) 2.25
Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum (1996) 2.20
Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum (2000) 2.12
Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet (1990) 2.11
Free-energy determinants of alpha-helix insertion into lipid bilayers. Biophys J (1996) 1.89
Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med (1984) 1.88
Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J (1973) 1.88
Automated ligand placement and refinement with a combined force field and shape potential. Acta Crystallogr D Biol Crystallogr (2006) 1.84
A randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis. Br J Rheumatol (1994) 1.79
Classical versus non-renal Wegener's granulomatosis. Q J Med (1994) 1.79
Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum (1999) 1.78
Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum (1995) 1.73
Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum (2001) 1.71
The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum (2001) 1.71
A district audit on the management of polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol (1994) 1.70
HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet (1974) 1.68
Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet (1999) 1.68
IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol (1981) 1.66
Classification and epidemiology of systemic vasculitis. Br J Rheumatol (1994) 1.63
The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology (Oxford) (2000) 1.59
Epidemiology of vasculitis in Europe. Ann Rheum Dis (2001) 1.58
An unusual cause of blindness in Wegener's granulomatosis. Rheumatology (Oxford) (1999) 1.54
The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen. J Biol Chem (1983) 1.52
Pyrophosphate arthropathy: a study of metabolic associations and laboratory data. Ann Rheum Dis (1982) 1.50
Wegener's granulomatosis in the elderly--unusual presentations and misdiagnosis. J Rheumatol (1994) 1.48
Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis (1987) 1.43
Sulphasalazine in rheumatoid arthritis: haematological problems and changes in haematological indices associated with therapy. Br J Rheumatol (1989) 1.41
Hug(h)e(s') ears: an unusual presentation of antiphospholipid syndrome. Ann Rheum Dis (1999) 1.38
Churg-Strauss syndrome in a district hospital. QJM (1998) 1.30
Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J Clin Pharmacol (1996) 1.29
Nuclease S1 mapping of a homozygous mutation in the carboxyl-propeptide-coding region of the pro alpha 2(I) collagen gene in a patient with osteogenesis imperfecta. Proc Natl Acad Sci U S A (1984) 1.29
Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable. J Clin Pharmacol (2000) 1.29
Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev (1997) 1.27
Organ donation. BMJ (1993) 1.27
Ethics and elective ventilation. Br J Hosp Med (1994) 1.25
Rectal biopsy in the diagnosis of systemic vasculitis. J Clin Pathol (1981) 1.25
Effect of weight-loss on plasma and urinary levels of uric acid. Lancet (1972) 1.25
Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases. Q J Med (1982) 1.24
Steroid-responsive nephrotic syndrome and allergy: immunological studies. Arch Dis Child (1981) 1.24
Berger disease: Henoch-Schönlein syndrome without the rash. J Pediatr (1985) 1.23
IgG antiglobulins in rheumatoid arthritis and other arthritides: relationship with clinical features and other parameters. Ann Rheum Dis (1981) 1.23
Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA. Postgrad Med J (1992) 1.23
Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis (2001) 1.21
Vasculitis-aims of therapy. An overview. Rheumatology (Oxford) (2000) 1.17
Polyarteritis and the kidney. Q J Med (1987) 1.16
Clinical variability of osteogenesis imperfecta reflecting molecular heterogeneity: cysteine substitutions in the alpha 1(I) collagen chain producing lethal and mild forms. J Biol Chem (1986) 1.11
Problems in the assessment of disease activity in ankylosing spondylitis. Rheumatol Rehabil (1981) 1.10
The incidence of rheumatoid vasculitis in the Norwich Health Authority. Br J Rheumatol (1994) 1.09
On the Effect of Acids, Alkalis, and Neutral Salts on the Fermentative Activity and on the Rate of Multiplication of Yeast Cells. Biochem J (1907) 1.07
Pharmacokinetics of mycophenolate mofetil (RS61443): a short review. Transplant Proc (1996) 1.05
Granulomatous mastitis--a rare cause of erythema nodosum. Postgrad Med J (1987) 1.04
Wegener's granulomatosis--increased incidence or increased recognition? Br J Rheumatol (1996) 1.04
Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36) in a community and a clinic based sample. Ann Rheum Dis (2001) 1.03
Alterations in the antigenic constitution of renal glomerular capillaries accompanying the histological maturation of renal glomeruli in the rat. Ann Rheum Dis (1967) 1.02
Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01
Pyrophosphate arthropathy: a clinical and radiological study of 105 cases. Ann Rheum Dis (1982) 1.01
Staphylococcal septicaemia, endocarditis, and osteomyelitis in dialysis and renal transplant patients. Postgrad Med J (1980) 1.01
Azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis. Br J Rheumatol (1998) 1.01
Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis. Ann Rheum Dis (1983) 0.99
The use of 'alternative treatments' by patients with rheumatoid arthritis. Rheumatol Int (1983) 0.98
Filaments in the division furrow of mouse mammary cells. J Cell Biol (1970) 0.98
Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol (1997) 0.98
What proteins are present in polyethylene glycol precipitates from rheumatic sera? Ann Rheum Dis (1989) 0.97
Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation. J Rheumatol (1996) 0.97
The Gaussian Generalized Born model: application to small molecules. Phys Chem Chem Phys (2007) 0.97
Jejunal mucosal immunoglobulins and complement in untreated coeliac disease. J Pathol (1977) 0.96
A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone. J Rheumatol (1994) 0.96
Letter: Acute anterior uveitis and HL-A 27. Lancet (1974) 0.94
Perceived numerosity as a function of item size. Percept Mot Skills (1988) 0.93
Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure. Thorax (1979) 0.93
Endothelial cell cytotoxicity in inflammatory vascular diseases--the possible role of oxidised lipoproteins. Ann Rheum Dis (1985) 0.92
Cutaneous vasculitis in a defined population--clinical and epidemiological associations. J Rheumatol (1998) 0.91
Chlamydia trachomatis and infertility. Lancet (1986) 0.90
Acute ulcerative acne conglobata (acne fulminans) with erythema nodosum. Clin Exp Dermatol (1977) 0.90
Activation of complement-a mechanism for the inflammation in acne. Br J Dermatol (1979) 0.89
Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. J Rheumatol (1997) 0.89
Side effect profile of 200 patients with inflammatory arthritides treated with sulphasalazine. Drugs (1986) 0.88
Determinants of the first decade of bone loss after menopause at spine, hip and radius. QJM (1999) 0.88
Enalapril in Raynaud's phenomenon. J Clin Pharm Ther (1988) 0.87
Comparison of the growth of the Ehrlich ascites tumor in male and female mice. Cancer Res (1967) 0.87
Isolated nail fold vasculitis in rheumatoid arthritis. Ann Rheum Dis (1995) 0.87
Clinical and biochemical observations on three cases of hypoxanthine-guanine phosphoribosyltransferase deficiency. Ann Rheum Dis (1975) 0.87
Primary renal vasculitis in Norfolk--increasing incidence or increasing recognition? Nephrol Dial Transplant (2000) 0.86
Retinal vasculitis in rheumatoid arthritis. Br Med J (Clin Res Ed) (1981) 0.86
Rat gastric acid secretion in response to graded subcutaneous doses of 2-deoxy-D-glucose. Am J Physiol (1966) 0.85